NATCOPHARM.BONATCOPHARM.BOBSE
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+6.2%
5Y CAGR+4.7%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+6.2%/yr
vs +10.0%/yr prior
5Y CAGR
+4.7%/yr
Consistent
Acceleration
-3.7pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.3x
Solid growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $6.00B | +12.0% |
| 2024 | $5.36B | +13.2% |
| 2023 | $4.73B | -5.4% |
| 2022 | $5.00B | +11.0% |
| 2021 | $4.51B | -5.6% |
| 2020 | $4.77B | +6.9% |
| 2019 | $4.47B | +30.5% |
| 2018 | $3.42B | +26.8% |
| 2017 | $2.70B | +40.7% |
| 2016 | $1.92B | - |